Warfarin tied to more drug interactions than DOACs in cancer patients
Direct-acting oral anticoagulants (DOACs) have fewer drug–drug interactions (DDIs) than warfarin, but the severity of interaction varies between DOACs, a recent study has found. In addition, some anticoagulant-drug interactions correlate with bleeding or venous thromboembolism (VTE).